Semax Amidate · Research brief
What Is Semax? (Semax Research Compound Explained)
Short answer
Semax was never designed as a nootropic. It's a chopped-down piece of a hormone the body already makes, the ACTH(4-7) fragment of adrenocorticotropic hormone, with the steroid-releasing activity engineered out and a three-amino-acid tail attached so plasma enzymes can't take it apart. That design detail is the entire story, and most write-ups skip it.
Key takeaways
- Semax is a synthetic heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro, built from the ACTH(4-7) fragment with the corticotropic activity removed.
- The Pro-Gly-Pro tail exists to resist aminopeptidase and carboxypeptidase cleavage, because unmodified ACTH fragments are degraded in plasma within minutes.
- The most cited finding in semax bdnf research is increased BDNF and trkB mRNA expression in rodent hippocampus after intranasal administration, which is a mechanism signal and not a clinical outcome.
- N-A Semax Amidate adds an N-terminal acetyl cap and a C-terminal amide cap, and is reported to be more metabolically stable than the parent peptide.
- Lyophilised material is generally held at -20C and protected from light, while reconstituted solutions are refrigerated at 2-8C and used within a limited window.
- Every semax research compound sold in the United States is research-use-only material, not an FDA-approved drug, and not for human or veterinary consumption.
- A batch-specific certificate of analysis showing HPLC purity and mass spectrometry identity is the only meaningful evidence that a vial contains what the label claims.
Semax was never designed as a nootropic. It's a chopped-down piece of a hormone the body already makes, the ACTH(4-7) fragment of adrenocorticotropic hormone, with the steroid-releasing activity engineered out and a three-amino-acid tail attached so plasma enzymes can't take it apart.
That design detail is the entire story, and most write-ups skip it. We supply research-grade peptides to laboratories, and the semax research compound draws more questions from our customers than almost anything else we stock.
What is the semax research compound?
The semax research compound is a synthetic heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro, developed in Russia as a metabolically stable analog of ACTH(4-7). Preclinical literature examines it mainly for effects on BDNF and NGF expression in brain tissue. It is research-use-only material, not an FDA-approved drug, and not for human or veterinary consumption.
Here's what that definition misses: the semax research compound is not a stimulant. The published work centres on neurotrophin signalling and monoamine modulation rather than adrenergic arousal, which is why semax cognitive research reads nothing like caffeine or amphetamine literature. What follows covers where the molecule came from, what the BDNF and NGF data actually report, and how N-Acetyl Semax Amidate differs in the lab.
Where Semax came from, and what the sequence does
Semax is a synthetic seven-amino-acid peptide developed by Russian researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences, and it is registered as a medicine in Russia. It holds no equivalent status in the United States, so every semax research compound sold here is research-use-only material with no approved therapeutic indication.
Why cut up a hormone in the first place? Full-length ACTH signals the adrenal cortex to release cortisol. The 4-7 fragment keeps the neurotropic activity described in the older regulatory-peptide literature while leaving the corticotropic signal behind. That was the point of the design, not an accident of it.
The problem with short fragments is speed of destruction. Native ACTH fragments are cleaved in plasma within minutes by aminopeptidases and carboxypeptidases, which makes them close to useless as experimental tools. The C-terminal Pro-Gly-Pro tail is the fix. Proline-rich sequences are poor substrates for those enzymes, and capping the sequence that way extends the exposure window enough to make the peptide workable in a study design.
Route matters too. The bulk of published work administers the peptide intranasally in rodent models, bypassing first-pass hepatic metabolism, which is why semax nasal spray research dominates the citation list and why liquid spray formats exist as a catalog item at all. In our experience, labs ordering a semax research compound for the first time almost always want to replicate that intranasal route, and the format choice follows from the protocol rather than the other way round.
What the BDNF and NGF research actually reports
BDNF (brain-derived neurotrophic factor) is the protein that supports neuron survival and synaptic plasticity by signalling through the TrkB receptor. The most frequently cited finding in semax bdnf research is that a single intranasal administration in rats is followed by increased BDNF and trkB mRNA expression in hippocampal tissue, alongside changes in NGF (nerve growth factor) expression. Research also suggests modulation of dopaminergic and serotonergic turnover and shifts in the balance between mature BDNF and its precursor, proBDNF.
Here's the part most summaries of semax nootropic research get wrong. The Pro-Gly-Pro tail is treated as inert packaging. It isn't. Pro-Gly-Pro belongs to the glyprolines, a family of short regulatory peptides with their own reported activity in the same body of literature, and it is liberated as the parent molecule is metabolised. Any lab running a semax research compound experiment that reads out downstream expression changes may be reading two signals at once: the intact heptapeptide and its released tail fragment. Control arms rarely account for that, and it's one of the first things our team flags when a customer asks how to design the comparison.
Be careful about what this evidence is. Increased mRNA expression in rodent hippocampus is a mechanism signal, not a clinical endpoint. It doesn't establish memory improvement, mood change, or any cognitive outcome in humans, and no large Western randomised controlled trial exists to make that jump for you.
Choosing a semax research compound: amidate analog, formats, and paperwork
N-Acetyl Semax Amidate, written in catalogs as N-A Semax Amidate or simply NASA, is the same heptapeptide with two chemical caps: an acetyl group on the N-terminus and an amide group on the C-terminus. Both modifications block the exopeptidases that trim peptides from either end. What n-a semax amidate research reports is greater metabolic stability and higher lipophilicity than the unmodified sequence, which is the reason a semax amidate research peptide is often selected when the experimental window is the limiting factor.
Format follows function. Lyophilised powder is stored frozen, typically at -20C and protected from light; once reconstituted, solutions are refrigerated at 2-8C and used within a limited window, because repeated freeze-thaw cycling degrades short peptides faster than most people expect. Premixed liquid sprays exist to match the intranasal route used in the source literature without a reconstitution step.
Then there's the paperwork, which is where sourcing quality actually lives. A certificate of analysis should show HPLC purity and mass spectrometry identity confirming the expected molecular weight for that exact sequence. Our published certificates of analysis are batch-specific, and we supply both N-A Semax Amidate and a Semax liquid spray as small-batch synthesised research materials. This article is research education, not guidance for use in people or animals; if you have a question about an animal's health, talk to your veterinarian, and for your own health, a licensed physician.
How Semax, the amidate analog, and Selank compare
Choosing a semax research compound usually comes down to stability and literature base rather than potency. The table below maps each structural difference against what the published work emphasises.
| Compound | Structural difference | What the literature emphasises | Common research format | Bottom line for lab selection |
|---|---|---|---|---|
| Semax | ACTH(4-7) plus a C-terminal Pro-Gly-Pro tail | Largest body of BDNF, NGF and behavioural model data of the four | Lyophilised powder or liquid spray | The default when the goal is replicating or extending existing published work |
| N-A Semax Amidate | Acetylated N-terminus and amidated C-terminus | Reported improvement in metabolic stability and lipophilicity over the parent sequence | Lyophilised powder or liquid spray | The choice when exopeptidase degradation is shortening the observable window |
| Selank | Tuftsin analog with the same Pro-Gly-Pro stabilising tail | Anxiolytic and immunomodulatory models rather than neurotrophin expression | Lyophilised powder or liquid spray | A different research question entirely, often run as a comparator arm |
| N-A Selank Amidate | Terminally capped Selank | Same stability rationale applied to the Selank sequence | Lyophilised powder | Useful only if the Selank literature is already central to the study design |
What If: Common Sourcing and Handling Scenarios
What if a lyophilised vial arrives at room temperature?
Record the condition on receipt and check the supplier's stability documentation before assuming the material is compromised. Lyophilised peptides are considerably more tolerant of short ambient excursions than reconstituted solutions, because water is the medium in which hydrolysis and microbial growth happen. The risk profile changes entirely once the powder is dissolved, which is why shipping is done dry.
What if plain Semax degrades faster than the experimental window requires?
Switching to the terminally capped analog is the standard response in the literature. Acetylation blocks aminopeptidase attack at the N-terminus and amidation blocks carboxypeptidase attack at the C-terminus, so na semax amidate research generally reports a longer intact-molecule window under comparable conditions. Run both arms if the endpoint is stability itself rather than a downstream readout.
What if two suppliers list the same peptide at very different purity?
Ask both for the batch-specific certificate, not a generic sample document. A semax research compound quoted at high purity without an accompanying HPLC trace and mass spectrometry identity confirmation for that lot number is an unverified claim. Purity figures also depend on the analytical method and gradient used, so identical numbers from different methods are not directly comparable.
What if the study needs to match the intranasal route used in published work?
A premixed liquid spray removes the reconstitution variable, which matters when consistency between sessions is the point. The trade-off is shelf stability: solutions have a shorter usable life than lyophilised powder held frozen. Most of the semax research products on the market exist in both formats precisely because that trade-off has no universally correct answer.
The unglamorous truth about Semax claims online
Let's be direct about this: the gap between what the literature reports and what the internet claims about Semax is enormous. Most of the human clinical work is Russian-language, decades old, modest in scale, and has not been replicated in large Western randomised controlled trials. The confident claims you'll read about focus, memory and recovery are extrapolations from rodent mRNA expression data, and extrapolation is not evidence. That doesn't make the compound uninteresting. It makes it exactly what it is labelled as, a research material with a genuinely intriguing mechanism and an incomplete evidence base.
If the Selank literature is also relevant to your work, our reference pages for Semax and Selank cover both sequences in more depth, and the catalog listings for Selank Amidate, Selank liquid spray and our oral research compounds sit alongside the rest of the full peptide range.
The semax research compound is a useful reminder that peptide design is mostly a fight against enzymes, not a search for exotic new mechanisms. Four residues of an old hormone did nothing useful on their own because plasma destroyed them on arrival. Add three amino acids that proteases find indigestible, cap both ends, and the same signal suddenly survives long enough to measure. Whatever the cognitive literature eventually settles on, that engineering lesson is the part that has already held up.
References
Peer-reviewed sources on Semax indexed in PubMed, listed for research context. Real Peptides supplies Semax for laboratory research use only.
- The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease. Acta naturae, 2025. PMID 41479572. doi:10.32607/actanaturae.27808
- Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing. Bioinorganic chemistry and applications, 2025. PMID 40496623. doi:10.1155/bca/4226220
- Functional Connectomic Approach to Studying Selank and Semax Effects. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2020. PMID 32342318. doi:10.1134/S001249662001007X
- Novel Insights into the Protective Properties of ACTH((4-7))PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats. Genes, 2020. PMID 32580520. doi:10.3390/genes11060681
- Influence of ACTG(4-7)-PGP (Semax) on Morphofunctional State of Hepatocytes in Chronic Emotional and Painful Stress. Bulletin of experimental biology and medicine, 2017. PMID 28577097. doi:10.1007/s10517-017-3748-4
- Peptides semax and selank affect the behavior of rats with 6-OHDA induced PD-like parkinsonism. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2017. PMID 28702721. doi:10.1134/S0012496617030048
- Semax prevents learning and memory inhibition by heavy metals. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2016. PMID 27411820. doi:10.1134/S0012496616030066
- The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study. Journal of molecular neuroscience : MN, 2011. PMID 20617398. doi:10.1007/s12031-010-9421-2
Build a pack
Researching more than one compound?
Build a multi-vial pack and the discount applies automatically as you add doses.
Questions
RESEARCH USE ONLY · NOT EVALUATED BY THE FDA